cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.5281/zenodo.5930115
title: Dataset related to article "Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi"

description: <br> This record contains raw data related to article “Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana Linfomi" We investigated the feasibility and activity of an intensifed dose-dense ABVD (dd-ABVD) regimen in patients with earlystage unfavorable Hodgkin lymphoma (HL). This prospective, multicenter, phase II study enrolled 96 patients with newly diagnosed, unfavorable stage I or II classical HL. The patients received four cycles of dd-ABVD followed by radiotherapy. Interim PET (PET-2) was mandatory after two courses. Primary endpoints were the evaluation of dd-ABVD feasibility and activity (incidence of PET-2 negativity). The feasibility endpoint was achieved with 48/52 (92.3%) patients receiving&gt;85% of the programmed dose. The mean dose intensity in the overall patient population (n=96) was 93.7%, and the median duration of dd-ABVD was 85 days (range, 14–115) versus an expected duration of 84 days. PET-2 was available for 92/96 (95.8%) patients, of whom 79 were PET-2 negative (85.9%). In total, 90 (93.8%) patients showed complete response at the end of treatment. With a follow-up of 80.9 months (3.3–103.2), the median progression-free survival (PFS) and overall survival (OS) were not reached. At 84 months, PFS and OS rates were 88.4% and 95.7%, respectively. No evidence for a diference in PFS or OS was observed for PET-2-negative and PET-2-positive patients. Infections were documented in 8.3% and febrile neutropenia in 6.2% of cases. Four patients died: one had alveolitis at cycle 3, one death was unrelated to treatment, and two died from a secondary cancer. dd-ABVD is feasible and demonstrates activity in early-stage unfavorable HL. The predictive role of PET-2 positivity in early-stage unfavorable HL remains controversial. The study was registered in the EudraCT (reference number, 2011–003,191-36) and the ClinicalTrials.gov (reference number, NCT02247869) databases.
DOI: 10.6084/m9.figshare.19096847
title: Matriz RS sobre la Eficiencia en Educación en la Enseñanza Secundaria_RIE.docx

description: Matriz sobre la Eficiencia en Educación en la Enseñanza Secundaria
DOI: 10.6084/m9.figshare.19096847.v1
title: Matriz RS sobre la Eficiencia en Educación en la Enseñanza Secundaria_RIE.docx

description: Matriz sobre la Eficiencia en Educación en la Enseñanza Secundaria
DOI: 10.5281/zenodo.5930301
title: Dataset related to article "Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer"

description: This record contains raw data related to article “Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer" Because the risk of relapse of node-negative breast cancer (BC) is largely varying, we evaluated the prognosis of a cohort of 1276 patients with this disease and the factors associated with increased risk of relapse. Overall, in nodenegative BC, age, hormonal receptor status, tumor size, and Ki67 were prognostic factors. The triple-negative BC subtype was not associated with a poorer prognosis compared with the human epidermal growth factor receptor 2-positive subtype, but showed a worse overall survival compared with luminal-like BC. Background: Because the risk of relapse of node-negative breast cancer (BC) is varying, we evaluated the prognosis of patients with this disease and the factors associated with increased risk of relapse. Patients and Methods: The clinical charts of patients with BC with evidence of negative nodes and with a potential 5-year follow-up were retrospectively reviewed
DOI: 10.5517/ccdc.csd.cc1z2qrj
title: CCDC 1819878: Experimental Crystal Structure Determination

description: Related Article: Li Xu,  Ji-Xing Gao,  Xiao-Gang Chen,  Xiu-Ni Hua,  De-Hong Wu,  Weiqiang Liao|2019|Eur.J.Inorg.Chem.|2019|800|doi:10.1002/ejic.201801293
DOI: 10.5517/ccdc.csd.cc1zrtg0
title: CCDC 1840143: Experimental Crystal Structure Determination

description: Related Article: Hai‐Lou Li, Zhong Zhang, Yue‐Lin Wang, Guo‐Yu Yang|2019|Eur.J.Inorg.Chem.|2019|486|doi:10.1002/ejic.201800546
DOI: 10.5281/zenodo.5930300
title: Dataset related to article "Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer"

description: This record contains raw data related to article “Biological Characteristics and Long-term Outcomes in Node-negative Breast Cancer" Because the risk of relapse of node-negative breast cancer (BC) is largely varying, we evaluated the prognosis of a cohort of 1276 patients with this disease and the factors associated with increased risk of relapse. Overall, in nodenegative BC, age, hormonal receptor status, tumor size, and Ki67 were prognostic factors. The triple-negative BC subtype was not associated with a poorer prognosis compared with the human epidermal growth factor receptor 2-positive subtype, but showed a worse overall survival compared with luminal-like BC. Background: Because the risk of relapse of node-negative breast cancer (BC) is varying, we evaluated the prognosis of patients with this disease and the factors associated with increased risk of relapse. Patients and Methods: The clinical charts of patients with BC with evidence of negative nodes and with a potential 5-year follow-up were retrospectively reviewed
DOI: 10.5517/ccdc.csd.cc1zwrxj
title: CCDC 1843939: Experimental Crystal Structure Determination

description: Related Article: Jiu-Nan Lu,  shu-fang zhou,  Sai-Jun Zhang,  Chen-Xi Zhang,  Qing-Lun Wang|2019|Eur.J.Inorg.Chem.|2019|794|doi:10.1002/ejic.201801084
DOI: 10.5517/ccdc.csd.cc1zw567
title: CCDC 1843359: Experimental Crystal Structure Determination

description: Related Article: Fateme Akhlaghi Bagherjeri,  Chris Ritchie,  Robert W. Gable, Colette Boskovic|2019|Eur.J.Inorg.Chem.|2019|461|doi:10.1002/ejic.201800598
DOI: 10.5517/ccdc.csd.cc1zw578
title: CCDC 1843360: Experimental Crystal Structure Determination

description: Related Article: Fateme Akhlaghi Bagherjeri,  Chris Ritchie,  Robert W. Gable, Colette Boskovic|2019|Eur.J.Inorg.Chem.|2019|461|doi:10.1002/ejic.201800598
DOI: 10.5517/ccdc.csd.cc1zw589
title: CCDC 1843361: Experimental Crystal Structure Determination

description: Related Article: Fateme Akhlaghi Bagherjeri,  Chris Ritchie,  Robert W. Gable, Colette Boskovic|2019|Eur.J.Inorg.Chem.|2019|461|doi:10.1002/ejic.201800598
DOI: 10.5517/ccdc.csd.cc1zw59b
title: CCDC 1843362: Experimental Crystal Structure Determination

description: Related Article: Fateme Akhlaghi Bagherjeri,  Chris Ritchie,  Robert W. Gable, Colette Boskovic|2019|Eur.J.Inorg.Chem.|2019|461|doi:10.1002/ejic.201800598
DOI: 10.5517/ccdc.csd.cc1z4b9r
title: CCDC 1821414: Experimental Crystal Structure Determination

description: Related Article: Jiancai Liu,  Hanbin Hu,  Xueying Jia,  Junwei Zhao,  Yu-Fei Song|2019|Eur.J.Inorg.Chem.|2019|534|doi:10.1002/ejic.201800653
DOI: 10.5517/ccdc.csd.cc1z4bbs
title: CCDC 1821415: Experimental Crystal Structure Determination

description: Related Article: Jiancai Liu,  Hanbin Hu,  Xueying Jia,  Junwei Zhao,  Yu-Fei Song|2019|Eur.J.Inorg.Chem.|2019|534|doi:10.1002/ejic.201800653
DOI: 10.5517/ccdc.csd.cc1z4b8q
title: CCDC 1821413: Experimental Crystal Structure Determination

description: Related Article: Jiancai Liu,  Hanbin Hu,  Xueying Jia,  Junwei Zhao,  Yu-Fei Song|2019|Eur.J.Inorg.Chem.|2019|534|doi:10.1002/ejic.201800653
DOI: 10.5517/ccdc.csd.cc20l2zp
title: CCDC 1864432: Experimental Crystal Structure Determination

description: Related Article: Hirofumi Oki,  Misaki Shiga,  Ippei Nakamura,  Kazuki Nishida,  Katsuya Ichihashi,  Sadafumi Nishihara,  Katsuya Inoue,  Tomoyuki Akutagawa,  Ryo Tsunashima|2019|Eur.J.Inorg.Chem.|2019|492|doi:10.1002/ejic.201801044
DOI: 10.5517/ccdc.csd.cc20l30r
title: CCDC 1864433: Experimental Crystal Structure Determination

description: Related Article: Hirofumi Oki,  Misaki Shiga,  Ippei Nakamura,  Kazuki Nishida,  Katsuya Ichihashi,  Sadafumi Nishihara,  Katsuya Inoue,  Tomoyuki Akutagawa,  Ryo Tsunashima|2019|Eur.J.Inorg.Chem.|2019|492|doi:10.1002/ejic.201801044
DOI: 10.5517/ccdc.csd.cc215m95
title: CCDC 1882236: Experimental Crystal Structure Determination

description: Related Article: Chao Liu,  Miao Li,  Yiquan Zhang,  Haiquan Tian,  Yuxiang Chen,  Hailong Wang,  Jianmin Dou, Jianzhuang Jiang|2019|Eur.J.Inorg.Chem.|2019|2940|doi:10.1002/ejic.201900440
DOI: 10.5517/ccdc.csd.cc215mc7
title: CCDC 1882238: Experimental Crystal Structure Determination

description: Related Article: Chao Liu,  Miao Li,  Yiquan Zhang,  Haiquan Tian,  Yuxiang Chen,  Hailong Wang,  Jianmin Dou, Jianzhuang Jiang|2019|Eur.J.Inorg.Chem.|2019|2940|doi:10.1002/ejic.201900440
DOI: 10.5517/ccdc.csd.cc219f2w
title: CCDC 1885887: Experimental Crystal Structure Determination

description: Related Article: Jennifer Möricke,  Atsushi Ueno,  Birgit Wibbeling,  Constantin G. Daniliuc,  Gerald Kehr,  Gerhard Erker|2019|Eur.J.Inorg.Chem.|2019|2912|doi:10.1002/ejic.201900505
DOI: 10.5517/ccdc.csd.cc219f3x
title: CCDC 1885888: Experimental Crystal Structure Determination

description: Related Article: Jennifer Möricke,  Atsushi Ueno,  Birgit Wibbeling,  Constantin G. Daniliuc,  Gerald Kehr,  Gerhard Erker|2019|Eur.J.Inorg.Chem.|2019|2912|doi:10.1002/ejic.201900505
DOI: 10.5517/ccdc.csd.cc219f4y
title: CCDC 1885889: Experimental Crystal Structure Determination

description: Related Article: Jennifer Möricke,  Atsushi Ueno,  Birgit Wibbeling,  Constantin G. Daniliuc,  Gerald Kehr,  Gerhard Erker|2019|Eur.J.Inorg.Chem.|2019|2912|doi:10.1002/ejic.201900505
DOI: 10.5517/ccdc.csd.cc219f5z
title: CCDC 1885890: Experimental Crystal Structure Determination

description: Related Article: Jennifer Möricke,  Atsushi Ueno,  Birgit Wibbeling,  Constantin G. Daniliuc,  Gerald Kehr,  Gerhard Erker|2019|Eur.J.Inorg.Chem.|2019|2912|doi:10.1002/ejic.201900505
DOI: 10.5517/ccdc.csd.cc219f60
title: CCDC 1885891: Experimental Crystal Structure Determination

description: Related Article: Jennifer Möricke,  Atsushi Ueno,  Birgit Wibbeling,  Constantin G. Daniliuc,  Gerald Kehr,  Gerhard Erker|2019|Eur.J.Inorg.Chem.|2019|2912|doi:10.1002/ejic.201900505
DOI: 10.5517/ccdc.csd.cc21bv8j
title: CCDC 1887257: Experimental Crystal Structure Determination

description: Related Article: Zdeňka Růžičková,  Roman Jambor,  and Miroslav Novák|2019|Eur.J.Inorg.Chem.|2019|3335|doi:10.1002/ejic.201900516
DOI: 10.5517/ccdc.csd.cc21bv9k
title: CCDC 1887258: Experimental Crystal Structure Determination

description: Related Article: Zdeňka Růžičková,  Roman Jambor,  and Miroslav Novák|2019|Eur.J.Inorg.Chem.|2019|3335|doi:10.1002/ejic.201900516
DOI: 10.5517/ccdc.csd.cc21bvbl
title: CCDC 1887259: Experimental Crystal Structure Determination

description: Related Article: Zdeňka Růžičková,  Roman Jambor,  and Miroslav Novák|2019|Eur.J.Inorg.Chem.|2019|3335|doi:10.1002/ejic.201900516
DOI: 10.5517/ccdc.csd.cc21bvcm
title: CCDC 1887260: Experimental Crystal Structure Determination

description: Related Article: Zdeňka Růžičková,  Roman Jambor,  and Miroslav Novák|2019|Eur.J.Inorg.Chem.|2019|3335|doi:10.1002/ejic.201900516
DOI: 10.5517/ccdc.csd.cc21bvdn
title: CCDC 1887261: Experimental Crystal Structure Determination

description: Related Article: Zdeňka Růžičková,  Roman Jambor,  and Miroslav Novák|2019|Eur.J.Inorg.Chem.|2019|3335|doi:10.1002/ejic.201900516
DOI: 10.5517/ccdc.csd.cc21bvfp
title: CCDC 1887262: Experimental Crystal Structure Determination

description: Related Article: Zdeňka Růžičková,  Roman Jambor,  and Miroslav Novák|2019|Eur.J.Inorg.Chem.|2019|3335|doi:10.1002/ejic.201900516
DOI: 10.5517/ccdc.csd.cc1jbv1r
title: CCDC 1410594: Experimental Crystal Structure Determination

description: Related Article: Selvakumar Balasubramaniam,  Sandeep Kumar,  Alex P. Andrews,  Babu Varghese,  Eluvathingal D. Jemmis,  Ajay Venugopal|2019|Eur.J.Inorg.Chem.|2019|3265|doi:10.1002/ejic.201900459
DOI: 10.5517/ccdc.csd.cc21nllx
title: CCDC 1896629: Experimental Crystal Structure Determination

description: Related Article: Christian Honacker,  Benedikt Kappelt,  Mirosław Jabłoński,  Alexander Hepp,  Marcus Layh,  Friedhelm Rogel,  Werner Uhl|2019|Eur.J.Inorg.Chem.|2019|3287|doi:10.1002/ejic.201900543
DOI: 10.5517/ccdc.csd.cc21pd27
title: CCDC 1897388: Experimental Crystal Structure Determination

description: Related Article: Chang-Feng Wang,  Xiao-Wei Fan,  Yu-Hui Tan,  Wen-Juan Wei,  Yun Zhi Tang|2019|Eur.J.Inorg.Chem.|2019|2907|doi:10.1002/ejic.201900493
DOI: 10.5517/ccdc.csd.cc21qy4w
title: CCDC 1898878: Experimental Crystal Structure Determination

description: Related Article: Marta Viciano-Chumillas,  José M. Carbonell-Vilar,  Donatella Armentano,  Joan Cano|2019|Eur.J.Inorg.Chem.|2019|2982|doi:10.1002/ejic.201900323
DOI: 10.5517/ccdc.csd.cc21tvyp
title: CCDC 1901693: Experimental Crystal Structure Determination

description: Related Article: Leon J.P. van der Boon,  Jesper H. Hendriks,  Danny Roolvink,  Sean J. O'Kennedy,  Martin Lutz,  J. Chris Slootweg,  Andreas W. Ehlers,  Koop Lammertsma|2019|Eur.J.Inorg.Chem.|2019|3318|doi:10.1002/ejic.201900641
DOI: 10.5517/ccdc.csd.cc21tvzq
title: CCDC 1901694: Experimental Crystal Structure Determination

description: Related Article: Leon J.P. van der Boon,  Jesper H. Hendriks,  Danny Roolvink,  Sean J. O'Kennedy,  Martin Lutz,  J. Chris Slootweg,  Andreas W. Ehlers,  Koop Lammertsma|2019|Eur.J.Inorg.Chem.|2019|3318|doi:10.1002/ejic.201900641
DOI: 10.5517/ccdc.csd.cc21tw0s
title: CCDC 1901695: Experimental Crystal Structure Determination

description: Related Article: Leon J.P. van der Boon,  Jesper H. Hendriks,  Danny Roolvink,  Sean J. O'Kennedy,  Martin Lutz,  J. Chris Slootweg,  Andreas W. Ehlers,  Koop Lammertsma|2019|Eur.J.Inorg.Chem.|2019|3318|doi:10.1002/ejic.201900641
DOI: 10.5517/ccdc.csd.cc21vhdt
title: CCDC 1902296: Experimental Crystal Structure Determination

description: Related Article: Maxim Faraonov,  Nikita R. Romanenko,  Alexey V. Kuzmin,  Dmitri V. Konarev,  Alexander F. Shestakov,  Pavel A. Stuzhin,  Salavat S. Khasanov,  Akihiro Otsuka,  Hideki Yamochi,  Hiroshi Kitagawa,  Rimma N. Lyubovskaya|2019|Eur.J.Inorg.Chem.|2019|2918|doi:10.1002/ejic.201900511
DOI: 10.25739/naws-j240
title: DeGraaf_data_lateralFlow_comparison_Jan2022

description: This directory contains model parameterization (aquifer permeability), model outcomes (groundwater lateral flow, depletion, and groundwater discharge) and model evaluation outcomes
DOI: 10.5281/zenodo.5929530
title: Experimental results for Dynamics of an interfacial bubble controls adhesion mechanics in a van der Waals heterostructure

description: These are the COMSOL Multiphysics file used for our FEM calculations of frequency dispersion with gate voltage (\(V_g^{dc}\)) and stress at different values of \(V_g^{dc}\) for different conditions of graphene-hBN heterostructure interface. For the bubble growth rate equation, we considered linear gate-voltage dependence. Bubble growth will be restricted as the bubble diameter reaches the diameter of the drum. So the growth is conditional, it increases as the gate voltage increases with a constant slope till its radius reaches the drum radius (\(R_f \)); its governing equation is \(R_{\textrm{bub}}(V_g^{\textrm{dc}})=R_i+mV_g^{\textrm{dc}} for R_{bub}\leq R_f\) . Bubble growth stops at \(R_{bub} ≈ R_f \), where \(R_i \), \(R_f \)are the initial and final radii of the bubble and m is the increase in bubble radius per unit change in gate voltage (\(µm/V\)).
DOI: 10.5281/zenodo.5929529
title: Experimental results for Dynamics of an interfacial bubble controls adhesion mechanics in a van der Waals heterostructure

description: These are the COMSOL Multiphysics file used for our FEM calculations of frequency dispersion with gate voltage (\(V_g^{dc}\)) and stress at different values of \(V_g^{dc}\) for different conditions of graphene-hBN heterostructure interface. For the bubble growth rate equation, we considered linear gate-voltage dependence. Bubble growth will be restricted as the bubble diameter reaches the diameter of the drum. So the growth is conditional, it increases as the gate voltage increases with a constant slope till its radius reaches the drum radius (\(R_f \)); its governing equation is \(R_{\textrm{bub}}(V_g^{\textrm{dc}})=R_i+mV_g^{\textrm{dc}} for R_{bub}\leq R_f\) . Bubble growth stops at \(R_{bub} ≈ R_f \), where \(R_i \), \(R_f \)are the initial and final radii of the bubble and m is the increase in bubble radius per unit change in gate voltage (\(µm/V\)).
DOI: 10.5281/zenodo.5838445
title: Replication package for: Subjective Models of the Macroeconomy: Evidence From Experts and Representative Samples

description: <strong>This repository contains the replication scripts and data of the analyses of the paper: </strong> Andre, P., Pizzinelli, C., Roth, C., & Wohlfart, J. (2022). Subjective Models of the Macroeconomy: Evidence From Experts and Representative Samples. <em>Review of Economic Studies</em>.
DOI: 10.6084/m9.figshare.19096907
title: Supplementary Material for: Real-world effectiveness of piperacillin/tazobactam with and without linezolid for spontaneous bacterial peritonitis

description: Background: Guidelines recommend empiric therapy with piperacillin/tazobactam (TZP) for spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant organisms. Whether coverage of beta-lactam-resistant Gram-positive bacteria, such as ampicillin-resistant Enterococcus faecium, provides clinical benefit in such situations is unknown. Methods: In this observational study, we investigated the real-world effectiveness of empirical therapy with TZP monotherapy versus TZP plus linezolid (LZD) combination therapy in patients with SBP from two centers. Treatment failure, defined as the need to escalate antibiotic therapy due to in vitro resistance, lack of neutrophil decrease in ascitic fluid, or clinical decision, and 30-day survival were retrospectively assessed. Results: In the first cohort, 100 SBP episodes were empirically treated with TZP+LZD combination therapy (n=50) or PTZ monotherapy (n=50). Treatment failure was recorded in 48% with TZP monotherapy compared with 16% with TZP+LZD combination therapy (P=0.001), and this difference persisted after stratification for community-acquired versus hospital-acquired SBP. Although treatment failure after TZP therapy was associated with lower 30-day survival (56% vs 82%; P=0.04), 30-day survival with empirical TZP+LZD combination therapy was not different from empirical TZP monotherapy (Kaplan-Meier estimates 74% vs 69%; P=0.87). TZP concentrations in ascitic fluid were &gt;32 mg/l in 94% samples after continuous administration. In a second cohort of 41 patients empirically treated with TZP, treatment failure was observed in 37%, which was also higher than in episodes treated with TZP+LZD in cohort 1 (P=0.03). Conclusion: In this retrospective analysis, empirical TZP+LZD combination therapy for SBP was associated with fewer treatment failures without impact on short-term survival.
DOI: 10.6084/m9.figshare.19096907.v1
title: Supplementary Material for: Real-world effectiveness of piperacillin/tazobactam with and without linezolid for spontaneous bacterial peritonitis

description: Background: Guidelines recommend empiric therapy with piperacillin/tazobactam (TZP) for spontaneous bacterial peritonitis (SBP) with low risk of multidrug-resistant organisms. Whether coverage of beta-lactam-resistant Gram-positive bacteria, such as ampicillin-resistant Enterococcus faecium, provides clinical benefit in such situations is unknown. Methods: In this observational study, we investigated the real-world effectiveness of empirical therapy with TZP monotherapy versus TZP plus linezolid (LZD) combination therapy in patients with SBP from two centers. Treatment failure, defined as the need to escalate antibiotic therapy due to in vitro resistance, lack of neutrophil decrease in ascitic fluid, or clinical decision, and 30-day survival were retrospectively assessed. Results: In the first cohort, 100 SBP episodes were empirically treated with TZP+LZD combination therapy (n=50) or PTZ monotherapy (n=50). Treatment failure was recorded in 48% with TZP monotherapy compared with 16% with TZP+LZD combination therapy (P=0.001), and this difference persisted after stratification for community-acquired versus hospital-acquired SBP. Although treatment failure after TZP therapy was associated with lower 30-day survival (56% vs 82%; P=0.04), 30-day survival with empirical TZP+LZD combination therapy was not different from empirical TZP monotherapy (Kaplan-Meier estimates 74% vs 69%; P=0.87). TZP concentrations in ascitic fluid were &gt;32 mg/l in 94% samples after continuous administration. In a second cohort of 41 patients empirically treated with TZP, treatment failure was observed in 37%, which was also higher than in episodes treated with TZP+LZD in cohort 1 (P=0.03). Conclusion: In this retrospective analysis, empirical TZP+LZD combination therapy for SBP was associated with fewer treatment failures without impact on short-term survival.
DOI: 10.5281/zenodo.5931178
title: An overview of bioinformatics, genomics and transcriptomics resources for bryophytes. Supplemental data

description: supplemental data file 1 - bryophyte transcriptomes
DOI: 10.5281/zenodo.5931177
title: An overview of bioinformatics, genomics and transcriptomics resources for bryophytes. Supplemental data

description: supplemental data file 1 - bryophyte transcriptomes
DOI: 10.5519/qd.wsehgymc
title: Query on the Natural History Museum Data Portal (data.nhm.ac.uk) (9 records)
DOI: 10.5281/zenodo.5931364
title: Single bias image from test of CCD

description: A single bias frame from a themo-electrically cooled CCD camera. Taken as part of a sequence of test images after initially receiving the camer.
DOI: 10.5281/zenodo.5931363
title: Single bias image from test of CCD

description: A single bias frame from a themo-electrically cooled CCD camera. Taken as part of a sequence of test images after initially receiving the camer.
DOI: 10.5281/zenodo.5931370
title: Cytotoxicity and estrogenicity of 3D printed orthodontic aligners

description: Dataset for all analyses
DOI: 10.5281/zenodo.5931369
title: Cytotoxicity and estrogenicity of 3D printed orthodontic aligners

description: Dataset for all analyses
DOI: 10.5281/zenodo.5874604
title: Phantom ISMRMRD datasets for "MaxGIRF: Image Reconstruction Incorporating Concomitant Field and Gradient Impulse Response Function Effects"

description: Phantom ISMRMRD datasets for "MaxGIRF: Image Reconstruction Incorporating Concomitant Field and Gradient Impulse Response Function Effects". Code to process and reconstruct the data is available here: https://github.com/usc-mrel/lowfield_maxgirf
DOI: 10.5281/zenodo.5874603
title: Phantom ISMRMRD datasets for "MaxGIRF: Image Reconstruction Incorporating Concomitant Field and Gradient Impulse Response Function Effects"

description: Phantom ISMRMRD datasets for "MaxGIRF: Image Reconstruction Incorporating Concomitant Field and Gradient Impulse Response Function Effects". Code to process and reconstruct the data is available here: https://github.com/usc-mrel/lowfield_maxgirf